Deregulated protein kinases: friend and foe in ischemic stroke
S Appunni, D Gupta, M Rubens, V Ramamoorthy… - Molecular …, 2021 - Springer
Ischemic stroke is the third leading cause of mortality worldwide, but its medical
management is still limited to the use of thrombolytics as a lifesaving option. Multiple …
management is still limited to the use of thrombolytics as a lifesaving option. Multiple …
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated …
Background multiple sclerosis (MS) is a complex disease sustained by several pathogenic
mechanisms. As such, combination therapy strategies, targeting a range of disease …
mechanisms. As such, combination therapy strategies, targeting a range of disease …